The requirements for expression of genes under the control of early (alkaline exonuclease) and late (VP5) herpes simplex virus type 1 (HSV-1) gene promoters were examined in a transient expression assay, using the bacterial chloramphenicol acetyltransferase gene as an expression marker. Both promoters were induced, resulting in the production of high levels of the enzyme upon low-multiplicity infection by HSV-1. Si nuclease analysis of hybrids between RNA isolated from infected cells containing HSV-1 promoter constructs and marker gene DNA demonstrated normal transcriptional initiation of the marker gene directed by the viral promoters. Viral DNA sequences no more than 125 bases 5' of the putative transcriptional cap site were sufficient for maximum activity of the late promoter. In contrast to expression controlled by the early gene, the late promoter was not active at a measurable level in uninfected cells until DNA sequences between 75 and 125 bases 5' of the transcriptional cap site were deleted. Cotransfection of cells with the expression marker controlled by HSV promoters and a cosmid containing HSV a (immediate-early) genes indicated that full expression of both early and late promoters requires the same virus-induced host cell modifications. Inhibition of viral DNA synthesis results in an increased rate of transient expression of marker genes under control of either early or late promoters in contrast to the situation in normal virus infection. These data provide evidence that the normal course of expression of late HSV genes involves negative modulation of potentially active promoters in the infected cell.
Herpes simplex virus type 1 (HSV-1) transcription is temporally regulated in a cascade fashion with controls at both the transcriptional (for review, see reference 60 ) and the translational levels (36) . The first group of transcripts expressed following infection are the immediate-early or a genes (1, 8, 9, 37, 63) . Since these transcripts are abundantly expressed in the absence of viral protein synthesis, it is clear that their transcription requires no viral gene expression. Proteins encoded by these genes appear to be regulatory in function (32, 35) . One a gene product (ICP4) is absolutely required throughout infection to allow further expression of genes from the viral genome (39, 51, 62) . Normal levels of a gene transcription are controlled in part by the presence of regulatory elements in or upstream of the actual promoters. The interaction between components of these regulatory elements and a virion-associated protein(s) results in marked stimulation of transcriptional activity in several marker systems (11, 40, 41, 43, 50, 51) .
The early or P genes are expressed after induction of immediate-early proteins in the infected cell. Early transcripts are present at relatively high levels in the absence of viral DNA replication (9, 31) . When these promoters are removed from the environment of the viral genome, they can be expressed in an uninfected cell in vitro transcription extract (23, 54) . The DNA sequences necessary for expression of thymidine kinase (TK), an early gene, have been studied as a model eucaryotic promoter in uninfected cells (46, 47 However, P promoters can be stimulated by exogenous enhancers. For example, when simian virus 40 enhancer is placed upstream from an early promoter, higher transcriptional activity results (20) .
Several research groups have studied the requirements for stimulating expression of early viral genes by HSV superinfection in cell lines containing early genes (55, 58) . The DNA sequences required for this stimulation were no greater than 200 bases upstream from the mRNA cap site (58) .
Everett (19) has performed several elegant studies with the early gD promoter in a transient transcription assay system and determined that only 83 base pairs 5' to the transcription cap site are required for induction of expression after viral superinfection. In a similar transient assay system, the TK early promoter was shown to require 109 bases upstream from the cap site for HSV-1-induced transcription (Elkareh et al., in press). The transcriptional stimulation induced by HSV infection is not specific to HSV promoter sequences. It has been demonstrated that herpes virus immediate-early products can induce or increase expression from a number of heterologous eucaryotic promoters. These include the adenovirus E2 promoter (34) , the ,-globin and simian virus 40 early promoter lacking enhancer sequences (21, 28) , and the Moloney murine leukemia virus long terminal repeat promoter lacking its upstream enhancer (R. H. Costa, E. K. Wagner, G. Feuer, and H. Fan, unpublished data).
DNA replication. However, they do not reach a normal level of expression until the initiation of viral DNA replication.
Qualitatively, the differentiation between a r3y and a P gene is based on the ease of detection of the transcript prior to or in the absence of viral DNA replication (60, 61) .
The -y or full late genes require viral DNA replication to observe detectable levels of transcripts and obtain normal expression from their promoters (10, 30, 38 (61) . In spite of this, at least some late promoters appear to be inactive in uninfected cells (16, 57) . Further, the VP5 promoter is inactive in an uninfected in vitro transcription system (23 In several experiments, a second model early HSV-1 promoter was used. This was the promoter for 5.2-kilobase (kb) early transcript mapping between 0.563 and 0.596 m.u., which has been described previously (2, 18) . This transcript is an extremely abundant one and encodes a protein (ICP6) important in the viral ribonucleotide reductase complex (33) . A HindIII linker was introduced into the KpnI site at 0.563 m.u., which is at the cap site of the transcript (23) . The PvuII site (0.554 m.u.) 1,300 bases 5' of the cap site was similarly converted into a Sall site and this fragment was introduced into the CAT plasmid. This construct is called RRductase-CAT.
Transfection and CAT assay. Prior to all transient expression assays, the cells were inspected for their growth properties to ensure that the difference observed in the CAT assays among different HSV-1 expression marker constructions was not due to the cells' viability. HeLa cells (2 x 106 cells) were plated out 24 h prior to DNA transfection into 75-cm2 tissue culture flasks (Corning Glass Works) containing Eagle minimal essential medium supplemented with 10% calf serum. The cells were plated so that they would reach 50 to 70% confluency before DNA transfection.
The procedure for the calcium phosphate coprecipitation of DNA onto cells was essentially as described by Busslinger et al. (6) . At 4 h before addition of the calcium phosphate precipitate to the cells, the medium was removed and replaced with Dulbecco modified Eagle medium containing 10% fetal calf serum. The HSV-1 promoter CAT expression marker plasmid (25 jig) was ethanol precipitated and suspended in 450 ,ul of 2 mM Tris (pH 7.6)-0.2 mM EDTA, followed by the addition of 50 ,ul of 2.5 M CaCl2. Then, 500 RI1 of 2x HEPES-buffered saline (280 mM NaCl, 50 mM HEPES [N-2-hydroxyethylpeperazine-N-2:ethanesulfonic acid], 1.5 mM Na2HPO4, pH 7.15) was added and vortexed vigorously to ensure that a very fine precipitate formed. After 1 h, the precipitate was added to the cells and allowed to incubate for 18 h. The medium containing the precipitate was removed, and the cells were rinsed with 1 x Trisbuffered saline (150 mM NaCl, 20 mM Tris, pH 7.6) and then overlaid with Dulbecco modified Eagle medium containing 10% fetal calf serum.
Cells that had been transfected with HSV-1 promoter CAT plasmids were either infected with HSV-1 at a multiplicity of 2 PFU per cell or mock infected 12 to 24 h after removal of the medium containing the DNA precipitant. In the experiment in which HSV-1 promoter CAT vectors were cotransfected with the HindIll fragment C cosmid, the CAT activity was determined 48 h after the DNA was introduced into the HeLa cells.
The efficiency of transfection with investigated by determining the amount of HSV-1 expression marker DNA present in nuclei of cells that were transfected with expression marker plasmids. Nuclei were isolated by Dounce homogenization in Nonidet-P-40 containing reticulocyte standard buffer, and total cellular DNA was isolated by phenol extraction. Plasmid DNA was quantitated by dot blotting, using a nick-translated CAT construct as a probe. There was little variability in the DNA-transfecting efficiency if the plasmid DNA used for each transfection experiment was always isolated in an identical manner (data not shown). The copy number of the expression marker plasmids were also determined from nuclear DNA of transfected cells in the presence or absence of HSV-1 superinfection. In neither case was a difference found in the amount of CAT expression marker plasmid, thus excluding the possibility that viral superinfection influenced the copy number of inducing plasmid replication (data not shown).
Protein extracts from transfected cells were made and assayed for CAT activity essentially as described by Gorman et al. (27) . The (2, 3, 17, 18, 22, 24, 29) .
In situ RNA blots were previously described (14, 17, 24, 29) . Hybridization was for 36 h at 50°C in 50% formamide containing 0.4 M Na+-0.1 M HEPES (pH 8)-0.005 M EDTA-Denhardt solution (15) .
Transfected HeLa cells containing HSV-1 promoter CAT plasmids were superinfected with HSV-1 (2 PFU per cell), and total cellular RNA was isolated at 22 h p.i. as described above. Any DNA present in the total cellular RNA preparation was eliminated by pelleting the RNA through a 5.7 M CsCl pad in a Beckman SW50.1 rotor, centrifuged at 35,000 rpm (114,000 x g) for 12 h as described in Glisin et al. (25) . S1 nuclease analysis was essentially as described by Berk and Sharp (5) and previously (2, 12-14, 17, 18, 22-24, 29) . The appropriate HSV-1 promoter CAT expression plasmids were cut at the desired restriction endonuclease site, and the DNA was 5' end labeled with [y32P]ATP (3, 000 Ci/mmol; ICN Pharmaceuticals, Inc.). Using T4 polynucleotide kinase resulted in a specific activity of 100,000 cpm per ,ug of DNA. The DNA fragments then were denatured and strand separated on 5% acrylamide gels as described by Maxam and Gilbert (45) . The strand-separated DNA (from 10 ,ug of cloned DNA) was hybridized with 50 to 100 ,ug of total infected-cell RNA hybrids subjected to Si nuclease (Boehringer Mannheim) digestion as described before (2, 12-14, 17, 18, 22-24, 29) . S1 nuclease material was fractionated on a denaturing 5% acrylamide gel with 5' end-labeled Hinfl-and EcoRI-digested pBR322 DNA fragments as size standards.
RESULTS
Expression of a model early (13) replication (14) . The second was the late VP5 gene. The mRNA of this P-y gene encodes the major capsid protein and becomes extremely abundant late in infection, although it is readily detected prior to viral DNA replication (12, 13, 30) .
The influence of viral DNA replication on HSV gene expression following a low-multiplicity infection (2 PFU per cell) is shown in the experiment of Fig. 1 . In this experiment, RNA from cells maintained for 12 h p.i. with 50 ,ug of thymine arabinoside (Ara-T) per ml was size fractionated in parallel with RNA from cells infected at the same multiplicity of infection but without the drug. The RNA blots were hybridized with nick-translated DNA probes as described in Materials and Methods. The probe for the alkaline exonuclease transcript, as well as for other colinear mRNA, was BglII-XhoI fragment O-G (0.164 to 0.171 m.u.). The probe for the VP5 transcript was HindIII-BamHI fragment A-A' (0.262 to 0.268 m.u.). Each probe was approximately 1,000 bases in length and each was labeled to approximately the same specific activity. Therefore, the relative intensity of radioactivity hybridizing to each transcript is a rough measure of the relative steady-state concentration at the time of RNA isolation. The drug Ara-T is comparable to adenosine arabinoside in its efficiency of inhibiting viral DNA replication and does not require the presence of an adenosine deaminase inhibitor for its activity, as does adenosine arabinoside (30; C. Shipman, Jr., R. H. Costa, and E. K. Wagner, unpublished data).
It is clear that only the alkaline exonuclease transcript and the partially colinear 1.9-kb mRNA encoding the 60,000-dalton polypeptide are present in readily detectable amounts in the absence of DNA replication (Fig. 1, ALKXO (14) . Transcripts encoding the VP5 protein as well as the transcripts identified by this laboratory as encoding the 50,000-dalton capsid protein (14) are detectable without DNA replication. However, at this low multiplicity of infection, their steady-state level is only a fraction of that of the alkaline exonuclease transcript. In the presence of DNA replication (Fig. 1, DNA replication +) , there is a significant increase in the steady-state concentration of both the early and the late model transcripts. Densitometer tracings indicate that the amounts of alkaline exonuclease mRNA increased by a factor of 6 while the VP5 transcript increased by a factor of 30 after DNA replication. Indeed, after DNA replication the level of the VP5 transcript is greater than that of the alkaline exonuclease mRNA. Such data suggest that the continued synthesis of early transcripts after viral DNA replication involves the same type of templates that are involved in the expression of the late transcripts, yet late transcription is greatly enhanced. This observation is of importance when suggesting models to explain late transcription during HSV replication.
HSV infection induces high levels of viral promotercontrolled CAT activity. To examine the role of promoter specificity in the expression of early and late HSV-1 genes, several expression markers were constructed by using the promoters of the model genes described above. The sequence of the promoter region of the alkaline exonuclease gene was presented previously (14) . Convenient restriction endonuclease cleavage sites and characteristic features, including "TATA" and "CAAT" boxes, as well as the early "AC" string, are located schematically in Fig. 2A . The promoter for the VP5 gene has been located, and the sequence of the 100 or so bases immediately 5' of the transcript cap site has been reported (12) . A more extensive sequence of the DNA extending 350 bases 5' of the cap site is shown in Fig. 2B . A restriction endonuclease cleavage map of the DNA sequences immediately 5' of the VP5 transcript cap site and essential features of the promoter, including, TATA and CAAT boxes and an AT string, are shown schematically in Fig. 2C . General features of early and late HSV promoters have been reviewed (60, 61 CAT gene (56) as described in Materials and Methods. This marker gene was then used to assay promoter activity either before or after infection with HSV. CAT enzyme activity was expressed as a relative conversion of radiolabeled chloramphenicol into acetylated forms as described in Materials and Methods. When high activities were obtained, dilutions of the standard aliquots from a fixed number of cells were assayed. In such cases, the resulting activity was expressed as the product of the percent acetylation of chloramphenicol and the dilution factor from the standard concentration.
As shown in the next section, depending on the exact promoter used, the CAT expression markers were active at a low or undetectable level in uninfected HeLa cells. When HeLa cells transfected with HSV promoter-controlled CAT expression markers were superinfected with low multiplicities of HSV-1 (2 PFU per cell), high levels of enzymatic activity were induced. An experiment illustrating this is shown in Fig. 3A. Here (tracks i, ii, iii, and v) , the AE-CAT and various VP5-CAT expression markers were induced to express very high levels of the enzyme. The multiplicity of infection used in the experiment shown was determined to be optimum. Infections with higher multiplicities resulted in less total CAT activity being induced in the cell population (data not shown). These results are consistent with previous reports that HSV-induced stimulation or marker genes carried in stably transformed cells is multiplicity dependent (16, 55, 58) .
The activity of the different VP5-CAT expression markers was tested to estimate the minimum size of a promoter region required for induction of transcription by HSV superinfection. The data of Fig. 3A demonstrated that no more than 125 bases of HSV sequence was sufficient (track ii). In a second experiment (Fig. 3B, tracks i, iii) , it was found that the VP5(75)-CAT was sufficient to allow expression with HSV-1 superinfection. It appears that this smallest promoter is somewhat less active, however, since the total amount of CAT activity induced is at least 10-fold less than was seen when the larger DNA fragments were used as promoters.
The VP5(650R)-CAT marker was not induced by HSV superinfection (Fig. 3A, track iv) . This result suggests that the induction seen requires an actual viral promoter and is not a nonspecific effect of the construction. S1 nuclease analysis of hybrids between infected-cell RNA from Fig. 5 (track i) . Early HSV promoters induced a low but readily detectable level of CAT activity. Acetylation (ca. 1.5 to 2%) was consistently found in HeLa cells transfected with AE-CAT. An example of this observation is shown in Fig. 5 (track ii) legend to Fig. 3 and in the text. CAM, Chloramphenicol. ) shows fractionation of S1 nuclease-resistant DNA isolated by digestion of hybrids between the single-stranded DNA hybridization probe and total cell RNA isolated at 22 h p.i. from cells transfected with VP5(650)-CAT superinfected with HSV-1 (S) as described in Materials and Methods. The track marked (U) contains undigested DNA. Track (M) contains DNA size markers derived by Hinfl and EcoRI digestion of pBR322 as described previously (12, 14, 18, 24) . Track In contrast to the situation with early HSV-1 promoters, most of the VP5 promoter-controlled CAT expression markers were completely inactive in transfected HeLa cells in the absence of HSV-induced modifications (Fig. 5, tracks iii to vi). The VP5(75)-CAT marker did, however, induce measurable CAT activity in uninfected HeLa cells as is shown in the experiment illustrated in Fig. 3B (tracks ii and iv) . This observation was quite reproducible. However, different isolates of the construct appeared to differ somewhat in the total amount of activity induced. This result suggested that some feature of the HSV DNA sequence between bases -75 and -125 of the VP5 promoter blocked the uninfected cell's ability to recognize the VP5 promoter in the CAT expression marker. These data also suggest that the low level of CAT activity induced in cells containing the VP5(75)-CAT marker upon superinfection (Fig. 3B, tracks i and iii) (61) . Identification of the deoxypyrimidine triphosphatase (dUTPase) gene (53) and of the virion-associated a gene stimulatory protein (7) are described. Also indicated on the drawing as a reference point is the transcript for gC, which is also described (25) Fig. 6A . Cloned HindlIl fragment C was introduced with CAT expression markers containing early and late promoters into HeLa cells by cotransfection. In all cases, the transfection contained equal weights of the two plasmids. The three tested expression markers all induced significant CAT activity (Fig. 6B) . The AE-CAT expression marker showed the most activity (track ii). However, its activity in uninfected cells was equivalent to that of RRductase-CAT, another early promoter-driven marker (cf. tracks i and iii). That RRductase-CAT is induced to the same level as VP5(650)-CAT upon cotransfection with HindIll fragment C (cf. tracks iv and v) suggests that the higher activity of AE-CAT in such experiments is not due to a temporal class-specific differential promoter stimulation.
Inhibition of viral DNA replication appears to increase the rate of CAT expression in superinfected cells. When following the time course of induction of CAT activity after HSV superinfections, it was consistently observed that induction of CAT activity in superinfected cells was more rapid when the AE-CAT marker was used than when the VP5(650)-CAT marker was used. An example of this observation is shown in Fig. 7A and a summary of data establishing this is shown in Fig. 7B . Such an observation was consistent with several explanations, including the possibility that the VP5 promoter may require increased levels of the stimulatory factors present in infected cells for its maximum activity compared with the AE promoter. Measurements of mRNA levels in the infected cell at various times would be required to establish this fact.
I3ecause there appeared to be a differential rate of stimulation of CAT activity depending on whether an early or late viral promoter was used, the effect of inhibition of superinfecting viral DNA replication on the expression of CAT activity controlled by the AE and VP5 promoters was examined. HeLa cells were transfected with AE-CAT or VP5(650)-CAT, and HSV-1 superinfection was carried out in the presence or absence of Ara-T to inhibit viral DNA replication. At 12 h after infection, there was a greater stimulation of CAT activity with both promoters if DNA synthesis was inhibited (Fig. 8, tracks ii and iv) . These data reconfirm the conclusion that no virus-induced modifications of the cell requiring viral DNA replication are necessary for transcriptional activity of the model late gene. The decreased stimulation observed from the HSV-1-controlled marker genes when superinfecting viral DNA replication proceeds may be the result of induced transcription activity A. Fig. 1 (57) . (28, 34, 49, 55 press). These data clearly indicate that this is not the case when the VP5 promoter is introduced into the cell. The VP5 promoter is also inactive when stably integrated into the host cell until that cell is infected with HSV (16) . As recently reviewed (60) , this lack of activity of late HSV promoters is common, but exceptions have been noted. It is suggested here that the general lack of activity of late HSV promoters in uninfected cells is a reflection of aspects of the biology of HSV-1 replication that are, as yet, unknown.
In the case of the VP5 promoter, the blockage of its activity in uninfected cells appears to be due to some feature of the DNA sequences lying between 75 and 125 bases 5' of the cap site. These sequences may also be important in full activity of the VP5 promoter following virus-induced host modifications, but they do not appear to be absolutely required. Recent preliminary experiments carried out by this laboratory with G. Feuer and H. Fan suggest that the lack of activity of the VP5 promoter in uninfected cells is correlated with the inability of this promoter to respond to enhancer sequences. If these observations are confirmed, this would provide another difference between the VP5 promoter and early HSV promoters since the latter promoters have been shown to respond to upstream enhancer sequences (20) .
Our data strongly suggest that in the transient assay system, the VP5 promoter does not require regulatory sequences further upstream than 125 bases for HSV transcriptional activation. Several HSV-1 early promoters have been analyzed and they also do not appear to contain regulatory sequences upstream of the promoter which are required for virus-induced activation (19, 46, 47 (49) . Their observations could be the result of the strength of the early promoter chosen (20-fold greater than TK in uninfected cells) and be specific to that particular promoter. The system studied may also be important since O'Hare and Hayward observed that the simian virus 40 early promoter was not induced by HSV superinfection and they suggested that HSV-induced transcriptional stimulation is specific to only HSV promoters. This latter result is in contrast to the studies involving several heterologous eucaryotic promoters whose activity was increased by herpesvirus immediate-early products (21, 28, 34; Costa et al., unpublished data).
